Fernand Labrie

Publications

Page 7 of 8, showing 50 records out of 361 total, starting on record 301, ending on 350

Publication Category Year
61. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G. (1984) Combined antiandrogen blockade in adenocarcinoma of the prostate: the first application of a successful new therapeutic principle in hormone-dependent cancer, in: Arvis, G., ed. Second International Forum on Andrology, Expansion Scientifique Française, Paris, pp 163-196. Prostate Cancer 1984
60. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Members of LUPCP. (1984) Complete androgen blockade at start of treatment causes a dramatic improvement of survival in advanced prostate cancer, in: Labrie, F., Bélanger, A. et Dupont, A., eds: Proceedings of the International Symposium on LHRH and its analogues: Basic and Clinical Aspects, Excerpta Medica, pp 368-379. Prostate Cancer 1984
59. Labrie, F., Dupont, A., Bélanger, A., Members of LUPCP (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer, in: Labrie, F. et Proulx, L., eds: Endocrinology ICS 655, Excerpta Medica, pp 450-453. Prostate Cancer 1984
58. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Labrie, C., Members of LUPCP (1984) Medical castration with LHRH agonists and the need for combined treatment with an antiandrogen in prostate cancer, in: McKerns, K.W., ed. Hormonal Control of the Hypothalamic-Pituitary Gonadal Axis, New York, Plenum Press, pp 531-549. Prostate Cancer 1984
57. Labrie, F., Tremblay, Y., Bélanger, A., Dupont, A. (1984) Medical castration is easily achieved with LHRH agonists, in: Scierra, J.J., ed. 5th International Meeting on Fertility Control, Genoa, Italy, pp 49-60. Prostate Cancer 1984
56. Lefebvre, F.A., Bélanger, A., Pelletier, G., Labrie, F. (1984) Recovery of gonadal functions in the adult male rat following cessation of 5-month daily treatment with an LHRH agonist. J. Androl., 5: 181-192. Prostate Cancer 1984
55. Marchetti, B., Labrie, F. (1984) Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. J. Steroid Biochem., 20: 339-342. Prostate Cancer 1984
54. Raynaud, J.P., Bonne, C., Moguilewsky, M., Lefebvre, F.A., Bélanger, A., Labrie, F. (1984) The pure antiandrogen, RU23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate, 5: 299-311. Prostate Cancer 1984
53. Tremblay, Y., Bélanger, A., Labrie, F., Frenette, G., Dubé, J.Y., Tremblay, R.R. (1984) Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog. Prostate, 5: 631-638. Prostate Cancer 1984
52. Tremblay, Y., Bélanger, A., Lacoste, D., Giasson, M., Labrie, F. (1984) Selective inhibition of spermatogenesis in the presence of normal libido following combined treatment with an LHRH agonist and testosterone in the dog. Contraception, 30: 585-598. Prostate Cancer 1984
51. Bélanger, A., Labrie, F., Séguin, C., Cusan, L., Carmichael, R., Caron, S. (1983) Inhibition of testicular delta 4-androgen secretion in the rat by treatment with luteinizing hormone-releasing hormone, in: Negro-Vilar, A., ed. Male Reproduction and Fertility, New York, Raven Press, pp 127-139. Prostate Cancer 1983
50. Labrie, F. (1983) A new therapy in prostatic cancer. Urology Times, August. Prostate Cancer 1983
49. Labrie, F. (1983) Luteinizing hormone-releasing hormone agonists and fertility regulation. The 9th Jennifer Hallam Memorial Lecture. J. Obst. Gynecol., 3: S37-S46. Prostate Cancer 1983
48. Labrie, F., Bélanger, A., Carmichael, R., Séguin, C., Lefebvre, F.A., Faure, N., Dupont, A. (1983) Inhibition of the testicular steroidogenic pathway in experimental animals and men, in: D'Agata, R., Lipsett, M.B.,Polosa, P. et van der Molen, H.J., eds: Recent Advances in Male Reproduction: Molecular Basis and Clinical Implications, New York, Raven Press, pp 239-248. Prostate Cancer 1983
47. Labrie, F., Dupont, A., Bélanger, A., Husson, J.M., Raynaud, J.P. (1983) Nouveau traitement antihormonal avec un antiandrogène et un agoniste de la LHRH dans le cancer de la prostate. Ann. Endocrinol. (Paris), 44: 343-344. Prostate Cancer 1983
46. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Gareau, J., Fazekas, A.T.A., Sandow, J., Monfette, G. (1983) New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate, 4: 579-594. Prostate Cancer 1983
45. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Monfette, G., Laberge, J.G., Emond, J.P., Raynaud, J.P., Husson, J.M., Fazekas, A.T.A. (1983) New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogen. J. Steroid Biochem., 19: 999-1007. Prostate Cancer 1983
44. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Cusan, L., Raynaud, J.P., Husson, J.M., Fazekas, A.T. (1983) New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist. Horm. Res., 18: 18-27. Prostate Cancer 1983
43. Labrie, F., Dupont, A., Bélanger, A., Lefebvre, F.A., Raynaud, J.P. (1983) Nouvelle approche dans le traitement du cancer de la prostate: utilisation combinée d'un agoniste de la LHRH et d'un antiandrogène. J. Pharmacol. (Paris), 14 Suppl 3: 117-135. Prostate Cancer 1983
42. Carmichael, R., Bélanger, A., Caron, S., Labrie, F., Sairam, M.R. (1982) Comparative effects of LHRH agonist and ovine LH administration on testicular steroidogenesis in intact adult rat. Steroids, 40: 641-649. Prostate Cancer 1982
41. Faure, N., Labrie, F., Belanger, A., Lemay, A., Raynaud, J.P., Von der Ohe, M., Fazekas, A.T. (1982) Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (HOE-766) in young normal adult men. J. Endocrinol. Invest., 5: 355-360. Prostate Cancer 1982
40. Faure, N., Labrie, F., Lemay, A., Bélanger, A., Gourdeau, Y., Laroche, B., Robert, G. (1982) Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent LHRH agonist in adult men. Fertil. Steril., 37: 416-424. Prostate Cancer 1982
39. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Lacourcière, Y., Monfette, G., Laberge, J.G., Emond, J., Fazekas, A.T.A., Raynaud, J.P., Husson, J.M. (1982) New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and antiandrogen. Clin. Invest. Med., 5: 267-275. Prostate Cancer 1982
38. Lefebvre, F.A., Séguin, C., Bélanger, A., Caron, S., Sairam, M.R., Raynaud, J.P., Labrie, F. (1982) Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. Prostate, 3: 569-578. Prostate Cancer 1982
37. Resko, J., Bélanger, A., Labrie, F. (1982) Effects of chronic treatment with a potent LHRH agonist on serum LH and steroid levels in the male rhesus monkey. Biol. Reprod., 26: 378-384. Prostate Cancer 1982
36. Tolis, G., Ackman, D., Stellos, A., Mehta, A., Labrie, F., Fazekas, A.T.A., Comaru-Schally, A.M., Schally, A.V. (1982) Tumor growth inhibition in patients with prostatic caricnoma treated with luteinizing hormone-releasing hormone agonists. Proc. Natl. Acad. Sci. USA, 79: 1658-1662. Prostate Cancer 1982
35. Bélanger, A., Auclair, C., Séguin, C., Caron, S., Labrie, F. (1981) Prolactin stimulation of testicular steroid biosynthesis in the male rat. J. Androl., 2: 80-86. Prostate Cancer 1981
34. Bélanger, A., Caron, S., Cusan, L., Séguin, C., Auclair, C., Labrie, F. (1981) Inhibition of testicular androgen biosynthesis by treatment with LHRH agonists, in: McKerns, K.W., ed. Reproductive Processes and Contraception. International Society for Biochemical Endocrinology, New York, Plenum Press, pp 471-491. Prostate Cancer 1981
33. Faure, N., Lemay, A., Bélanger, A., Labrie, F. (1981) Inhibition of androgen biosynthesis in the human male by chronic administration of [D-Ser(TBU)6]-des-Gly-NH210]LHRH ethylamide, in: Zatuchni, G.I., Shelton, J.D. et Sciarra, J.J., eds: LHRH peptides as female and male contraceptive, Philadelphia, Harper & Row, pp 307-320. Prostate Cancer 1981
32. Labrie, F. (1981) Changing the message from the brain. People, 8: 16-17. Prostate Cancer 1981
31. Labrie, F., Bélanger, A., Kelly, P.A., Séguin, C., Cusan, L., Lefebvre, F.A., Reeves, J.J., Lemay, A., Faure, N., Laroche, B., Raynaud, J.P. (1981) Antifertility effects of LHRH agonists, in: Soto, R.J., De Nicola, A.F. et Blaquier, J.A., eds: Progress in Clinical and Biological Research. Physiopathology of Diseases and Mechanisms of Hormone Action, New York, Alan R. Liss Inc., pp 273-291. Prostate Cancer 1981
30. Labrie, F., Bélanger, A., Séguin, C., Cusan, L., Pelletier, G., Lefebvre, F.A., Kelly, P.A., Ferland, L., Reeves, J.J., Lemay, A., Raynaud, J.P. (1981) Inhibition of testicular and ovarian functions by LHRH agonists, in: Jagiello, G. et Vogel, H.J., eds: Bioregulators of Reproduction, New York, NY, USA, Academic Press, pp 305-341. Prostate Cancer 1981
29. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Kelly, P.A., Lefebvre, F.A., Massicotte, J., Borgus, J.P., Lemay, A., van der Ohe, M. (1981) Antifertility effects of LHRH agonists, in: Semm, K. et Mettler, L., eds: Proc. III World Congress on Human Reproduction, Excerta Medica, ICS 551, pp 116-125. Prostate Cancer 1981
28. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Massicotte, J., Kelly, P.A., Borgus, J.P. (1981) LHRH and sexual functions: inhibition at the pituitary and gonadal levels, in: Bizollon, C.A., ed. Physiological peptides and new trends in radioimmunology, Elsevier-North Holland, Biomedical Press, pp 57-70. Prostate Cancer 1981
27. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Reeves, J.J., Kelly, P.A., Massicotte, J., Cusan, L. (1981) LHRH and down regulation of testicular receptors and function, in: Frajese, G., ed. Oligospermia. Recent Progress in Andrology, New York, NY, USA, Raven Press, pp 337-345. Prostate Cancer 1981
26. Labrie, F., Godbout, M., Bélanger, A., Lefebvre, F.A., Séguin, C., Pelletier, G., Cusan, L., Kelly, P.A., Reeves, J.J. (1981) Mechanisms of the antifertility effects of LHRH agonists in the male rat, in: Shelton, J.D., Zatuchni, G.I. et Sciarra, J.J., eds: LHRH peptides as female and male contraceptives, Philadelphia, Harper & Row, pp 246-260. Prostate Cancer 1981
25. Séguin, C., Bélanger, A., Cusan, L., Pelletier, G., Reeves, J.J., Lefebvre, F.A., Kelly, P.A., Labrie, F. (1981) Relative importance of the adenohypophyseal and gonadal sites of inhibitory action of LHRH agonists. Biol. Reprod., 24: 889-901. Prostate Cancer 1981
24. Séguin, C., Cusan, L., Bélanger, A., Kelly, P.A., Labrie, F., Raynaud, J.P. (1981) Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat. Mol. Cell. Endocrinol., 21: 37-41. Prostate Cancer 1981
23. Bélanger, A., Auclair, C., Ferland, L., Caron, S., Labrie, F. (1980) Time-course of the effect of treatment with a potent LHRH agonist on testicular steroidogenesis and gonadotropin receptor levels in the adult rat. J. Steroid Biochem., 13: 191-196. Prostate Cancer 1980
22. Bélanger, A., Cusan, L., Auclair, C., Séguin, C., Caron, S., Labrie, F. (1980) Effect of an LHRH agonist and hCG on testicular steroidogenesis in the adult rat. Biol. Reprod., 22: 1094-1101. Prostate Cancer 1980
21. Bélanger, A., Cusan, L., Séguin, C., Caron, S., Labrie, F. (1980) Inhibition de la stéroïdogénèse testiculaire chez le rat par traitement avec un agoniste de la LHRH. Union Med. Can., 109: 489-494. Prostate Cancer 1980
20. Belanger, A., Labrie, F., Lemay, A., Caron, S., Raynaud, J.P. (1980) Inhibitory effects of a single intranasal administration of [D-Ser(TBU)6, des-Gly -NH210]LHRH ethylamide, a potent LHRH agonist, on serum steroid levels in normal adult men. J. Steroid Biochem., 13: 123-126. Prostate Cancer 1980
19. Labrie, F., Bélanger, A., Cusan, L., Séguin, C., Pelletier, G., Kelly, P.A., Reeves, J.J., Lefebvre, F.A., Lemay, A., Raynaud, J.P. (1980) Antifertility effects of LHRH agonists in the male. J. Androl., 1: 209-228. Prostate Cancer 1980
18. Labrie, F., Bélanger, A., Pelletier, G., Séguin, C., Cusan, L., Kelly, P.A., Lemay, A., Auclair, C., Raynaud, J.P. (1980) LHRH agonists: inhibition of testicular functions and possible clinical applications, in: Cunningham, G.R., Schill, W.B. et Hafez, E.S.E., eds: Clinics in Andrology. Regulation of Male Fertility, The Netherlands, Martinus Nijoff Publ., B.V., The Hague, pp 65-75. Prostate Cancer 1980
17. Labrie, F., Cusan, L., Séguin, C., Bélanger, A., Pelletier, G., Reeves, J., Kelly, P.A., Lemay, A., Raynaud, J.P. (1980) Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man. Int. J. Fertil., 25: 157-170. Prostate Cancer 1980
16. Pelletier, G., Cusan, L., Bélanger, A., Séguin, C., Kelly, P.A., Labrie, F. (1980) Further studies on the inhibitory effects of [D-Ala6, des-Gly-NH210]LHRH ethylamide on spermatogenesis and steroidogenesis in the rat: Reversibility and effect of androgen administration. J. Androl., 1: 171-181. Prostate Cancer 1980
15. Bélanger, A., Auclair, C., Séguin, C., Kelly, P.A., Labrie, F. (1979) Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin. Mol. Cell. Endocrinol., 13: 47-53. Prostate Cancer 1979
14. Cusan, L., Auclair, C., Bélanger, A., Ferland, L., Kelly, P.A., Séguin, C., Labrie, F. (1979) Inhibitory effects of long-term treatment with an LHRH agonist on the pituitary-gonadal axis in male and female rats. Endocrinology, 104: 1369-1376. Prostate Cancer 1979
13. Labrie, F., Auclair, C., Cusan, L., Lemay, A., Pelletier, G., Kelly, P.A., Bélanger, A., Séguin, C., Raynaud, J.P. (1979) Antifertility effects of LHRH and its agonists in male and female rats: possible luteolytic effects of LHRH in women, in: Talwar, G.P., ed. Recent Advances in Reproduction and Regulation of Fertility, Elsevier-North Holland, Biomedical Press, pp 57-71. Prostate Cancer 1979
12. Raynaud, J.P., Bonne, C., Bouton, M.M., Lagacé, L., Labrie, F. (1979) Action of a non -steroidal anti -androgen, RU23908, in peripheral and central tissues. J. Steroid Biochem., 11: 93-99. Prostate Cancer 1979
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards